NEW YORK (GenomeWeb) – A team led by researchers at the University of Alberta and Quest Diagnostics have completed a preclinical validation study that indicates the protein 14-3-3eta is a useful biomarker for rheumatoid arthritis.

In particular, their findings suggest that the protein has potential for improving early diagnosis and for identifying severe cases of the disease, Walter Maksymowych, a medical research professor at the University of Alberta and leader of the study, told ProteoMonitor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.